Key result
Female sex was not associated with a significant difference in 1-year ventricular tachycardia recurrence (38.24% vs 35.36%, p=0.74) or all-cause mortality compared to male sex following catheter ablation.
Why the study?
The study aimed to establish sex-specific predictors for 1-year VT recurrence and 1-year all-cause mortality in patients with structural heart disease undergoing catheter ablation.
Are there sex differences in 1-year recurrence and all-cause mortality following catheter ablation of ventricular tachycardia in patients with structural heart disease?
Observational (n=299)
No
Are there sex differences in 1-year recurrence and all-cause mortality following catheter ablation of ventricular tachycardia in patients with structural heart disease?
While overall 1-year VT recurrence and mortality rates after catheter ablation do not differ significantly by sex, the clinical predictors for these outcomes are highly sex-specific, highlighting the need for tailored risk stratification.
Answers are grounded in this paper and cite their sources.
No sex difference in VT ablation outcomes; leaves open whether sex-specific predictors warrant tailored stratification.
Aims: We aimed to establish sex-specific predictors for 1-year VT recurrence and 1-year all-cause mortality in patients with structural heart disease undergoing catheter ablation. Methods: We analyzed data of 299 patients recorded in our structured registry. These included medical history, echocardiography parameters, laboratory results, VT properties, procedural data. In females, severe mitral regurgitation (MR), tricuspid regurgitation (TR), presentation with incessant VT, and preprocedural electrical storm (ES) were associated with increased risk of VT recurrence. Diabetes, implanted CRT, VT with hemodynamic instability, ES and advanced MR were the risk factors of mortality in women. ACEi/ARB use predicted a favorable outcome in both endpoints among females. In men, independent predictors of VT recurrence were the composite parameter of ES and multiple ICD therapies, presentation with incessant VT, severe MR, while independent predictors of mortality were age, LVEF, creatinine and previously implanted CRT. Conclusion: According to our investigation, there are pronounced sex differences in predictors of recurrence and mortality following VT ablation.
No takes yet. Share an insight, caveat, or question.
Tóth et al. (2022) conducted an observational in Structural heart disease with sustained, monomorphic ventricular tachycardia (n=299). Female sex vs. Male sex was evaluated on 1-year ventricular tachycardia recurrence (p=0.74). Female sex was not associated with a significant difference in 1-year ventricular tachycardia recurrence (38.24% vs 35.36%, p=0.74) or all-cause mortality compared to male sex following catheter ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: